Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
In the last 90 days, Lipocine Inc. insiders filed 2 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Lipocine Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 39 | 44 | +5 |
| Shares | 10.6M | 11.9M | +1.30M (+12.2%) |
| Value | $10.5M | $16.2M | +$5.64M (+53.6%) |
New holders (9)
Institutions that held Lipocine Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EAM Investors, LLC | 657,804 | $901.0K | 0.17% |
| Marshall Wace, LLP | 562,670 | $771.0K | 0.00% |
| Bridgeway Capital Management, LLC | 176,864 | $242.0K | 0.00% |
| XTX Topco Ltd | 39,357 | $54.0K | 0.02% |
| Two Sigma Securities, LLC | 18,905 | $26.0K | 0.00% |
| Renaissance Technologies LLC | 14,100 | $19.0K | 0.00% |
| Citigroup Inc | 500 | $1.00K | 0.00% |
| Walleye Trading LLC | 101 | $0 | 0.00% |
| Aaron Wealth Advisors | 117,552 | – | – |
Sold out (4)
Institutions that held Lipocine Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 440,432 | $437.0K |
| HRT Financial LP | 24,180 | $23.0K |
| Pinnacle Private Wealth, LLC | 15,250 | $15.0K |
| ExodusPoint Capital Management, LP | 11,715 | $12.0K |